איקסמפרה 15 מ"ג

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

IXABEPILONE 15 MG

Pieejams no:

BRISTOL-MYERS SQUIBB (ISRAEL) LIMITED

ATĶ kods:

L01DC04

Zāļu forma:

POWDER FOR CONCENTRATE FOR INFUSION

Ievadīšanas:

I.V

Ražojis:

CORDEN PHARMA LATINA S.P.A., ITALY

Ārstniecības grupa:

IXABEPILONE

Ārstēšanas norādes:

Ixempra is indicated for the treatment of inoperable locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy:In combination with capecitabine in patients failing prior therapy with a taxane and an anthracycline or for whom further anthracycline therapy is not indicated.As monotherapy in patients failing prior therapy with taxanes, capecitabine and anthracyclines or for whom futher anthracycline therapy is not indicated.

Autorizācija datums:

2012-01-01